Mode of action: developmental thyroid hormone insufficiency--neurological abnormalities resulting from exposure to

R Thomas Zoeller1, Kevin M Crofton

  • 1University of Massachusetts-Amherst, Department of Biology, Morrill Science Center, 01003, USA. tzoeller@bio.umass.edu

Insights

Environmental chemicals disrupting thyroid hormone can harm brain development. While 6-n-propyl-2-thiouracil (PTU) affects thyroid levels, careful human monitoring prevents infant harm.

Area of Science:

  • Environmental toxicology
  • Developmental neurobiology
  • Endocrinology

Background:

  • Thyroid hormone is critical for prenatal and postnatal brain development.
  • Environmental chemicals interfering with thyroid signaling pose risks to neurodevelopment.
  • The impact of thyroid hormone disruptors varies with exposure timing and severity.

Purpose of the Study:

  • To systematically evaluate the mode of action (MOA) of 6-n-propyl-2-thiouracil (PTU) in rats and humans.
  • To assess the relevance of animal studies on PTU to human thyroid function and brain development.
  • To understand the potential risks of PTU exposure during critical developmental windows.

Main Methods:

  • Comparative analysis of PTU's mode of action in animal models (rats) and human clinical data.
  • Review of mechanistic studies on PTU's effects on thyroid hormone signaling.
  • Evaluation of data sets including both animal and human information on PTU.

Main Results:

  • PTU exhibits similar modes of action in both rats and humans.
  • The study predicts that PTU-induced thyroid hormone insufficiency could adversely impact the developing human brain.
  • Clinical use of PTU in pregnant and lactating women, with careful monitoring, maintains normal infant thyroid hormone levels.

Conclusions:

  • Environmental antithyroid factors, like PTU, require systematic evaluation for human relevance.
  • While PTU can cause thyroid hormone insufficiency, human clinical management strategies mitigate risks to infant brain development.
  • Understanding the MOA of chemical disruptors is crucial for predicting and preventing adverse developmental outcomes.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...